# The CJC-1295 shelf

> Idaho Hormones research bookshelf — The Idaho Hormones reading list brings together the CJC-1295 design, duration, pulse, mouse-growth and analytical papers, plus a GHRH review.

**Reading list**

A hormone trace, a growth result and a protein profile each earn a space on this shelf.

## Design and hormone measurements

The [albumin-bioconjugate paper](https://pubmed.ncbi.nlm.nih.gov/15817669/) follows the design into rat and laboratory experiments. The [healthy-adult duration study](https://pubmed.ncbi.nlm.nih.gov/16352683/) supplies the prolonged GH and IGF-1 measurements. The [pulse study in healthy men](https://pubmed.ncbi.nlm.nih.gov/17018654/) then examines the secretion pattern under sustained stimulation.

I pair the duration paper with the pulse paper. Seeing the two together makes the long signal more interesting than either a single concentration or the long-acting description alone.

## Growth, protein profiles and identification

The [GHRH-knockout mouse study](https://pubmed.ncbi.nlm.nih.gov/16822960/) changes the outcome to body weight and length. The [serum-protein study in healthy young adult men](https://pubmed.ncbi.nlm.nih.gov/19386527/) looks for biological traces of GH/IGF-1-axis activation. The [analytical-identification paper](https://doi.org/10.1002/dta.233) establishes the identity of CJC-1295 in an unknown preparation.

For broader context, [the review of GHRH and its analogues](https://pubmed.ncbi.nlm.nih.gov/39537825/) discusses receptor signaling, long-acting design and the therapeutic and investigational landscape. That breadth helps place the individual experiments in context. The direct CJC-1295 findings still come from the experiments themselves.

## References

[1] Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog https://pubmed.ncbi.nlm.nih.gov/15817669/
[2] Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults https://pubmed.ncbi.nlm.nih.gov/16352683/
[3] Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog https://pubmed.ncbi.nlm.nih.gov/17018654/
[4] Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse https://pubmed.ncbi.nlm.nih.gov/16822960/
[5] Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects https://pubmed.ncbi.nlm.nih.gov/19386527/
[6] Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation https://doi.org/10.1002/dta.233
[7] Growth hormone-releasing hormone and its analogues in health and disease https://pubmed.ncbi.nlm.nih.gov/39537825/

---

I follow long hormone signals through the published research at Idaho Hormones, a personal notebook with no healthcare business or medical advice behind its title.